LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Moderna Inc

Moderna Inc

Suletud

Sektor Tervishoid

72.88 -0.48

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

72.16

Max

73.08

Põhinäitajad
By Trading Economics
Sissetulek	-104M -1.3B
Müük	-167B 241M
P/E Sektori keskmine	35.86 103.001
Aktsiakasum	-3.33
Kasumimarginaal	-530.705
Töötajad	5,600
EBITDA	-109M -1.2B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+76.62 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	31. okt 2024

Turustatistika
By TradingEconomics
Turukapital	-65M 30B
Eelmine avamishind	73.36
Eelmine sulgemishind	72.88

Uudiste sentiment

By Acuity

31%

69%

58 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

71.62 / 77.46 Toetus ja vastupanu

Moderna Inc Graafik

Seotud uudised

13. dets 2023, 13:16 UTC

Suurimad hinnamuutused turgudel

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

14. okt 2023, 00:02 UTC

Kuumad aktsiad

Stocks to Watch: Pfizer, Moderna, Lululemon Athletica

11. sept 2023, 11:39 UTC

Suurimad hinnamuutused turgudel

Immatics Shares Rise Premarket on Collaboration With Moderna

6. sept 2024, 11:00 UTC

Peamised uudised

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3. sept 2024, 04:00 UTC

Peamised uudised

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23. aug 2024, 18:38 UTC

Peamised uudised

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2. aug 2024, 21:29 UTC

Peamised uudised

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1. aug 2024, 10:30 UTC

Peamised uudised

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3. juuli 2024, 14:18 UTC

Omandamised, ülevõtmised, äriostud

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30. mai 2024, 19:45 UTC

Peamised uudised

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29. mai 2024, 15:56 UTC

Tulu

Omandamised, ülevõtmised, äriostud

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10. mai 2024, 20:11 UTC

Tulu

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10. mai 2024, 14:49 UTC

Tulu

Kuumad aktsiad

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2. mai 2024, 13:46 UTC

Tulu

Kuumad aktsiad

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2. mai 2024, 10:31 UTC

Tulu

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2. mai 2024, 09:08 UTC

Kuumad aktsiad

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28. veebr 2024, 14:14 UTC

Tulu

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22. veebr 2024, 16:00 UTC

Peamised uudised

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22. veebr 2024, 12:40 UTC

Tulu

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

2. nov 2023, 16:53 UTC

Tulu

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat -- IBD

2. nov 2023, 08:58 UTC

Tulu

These Stocks Are Moving the Most Today: Qualcomm, PayPal, SolarEdge, Roku, DoorDash, E.l.f. Beauty, and More -- Barrons.com

31. okt 2023, 16:35 UTC

Peamised uudised

Tulu

Nevermind Covid, Investors Want a Pfizer Obesity Pill -- Heard on the Street -- WSJ

17. okt 2023, 10:00 UTC

Peamised uudised

Pfizer Looks for a Covid Bottom -- Heard on the Street -- WSJ

26. sept 2023, 09:30 UTC

Peamised uudised

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out -- WSJ

13. sept 2023, 12:00 UTC

Peamised uudised

Moderna Rises on Positive Results From Flu Vaccine, and Other Plans to Move Beyond Covid -- Barrons.com

12. sept 2023, 13:00 UTC

Peamised uudised

CDC Advisers Weigh Covid-19 Booster Guidance as Latest Variants Spread -- WSJ

11. sept 2023, 18:27 UTC

Peamised uudised

FDA Approves Newest Covid-19 Boosters -- Update

11. sept 2023, 17:55 UTC

Peamised uudised

FDA Approves Newest Covid-19 Boosters -- WSJ

11. sept 2023, 11:24 UTC

Suurimad hinnamuutused turgudel

Immatics Shares Rise Premarket on Collaboration With Moderna >IMTX

Võrdlus sarnastega

Hinnamuutus

Moderna Inc Prognoos

Hinnasiht

By TipRanks

76.62% tõus

12 kuu keskmine prognoos

Keskmine 129.71 USD 76.62%

Kõrge 310 USD

Madal 58 USD

Põhineb 19 Wall Streeti analüütiku instrumendi Moderna Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

19 ratings

Osta

Hoia

Müü

Põhineb 19 analüütiku instrumendi Moderna Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

71.62 / 77.46Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

58 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.